-
-
-
-
-
-
-
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
-
-
-
-
-
-
-
AnaptysBio Announces Second Quarter 2023 Financial Results and Provides Business Update
-
-
-
-
-
-
-
AnaptysBio Announces Stock Repurchase Plan
-
-
-
-
-
-
-
AnaptysBio Appoints Daniel Faga As Interim Chief Executive Officer
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/14: (MDRX) (NIO) (CXO) Higher; (CYCN) (ATEC) (AMC) Lower (more...)
-
-
-
1,168,812 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

